Cleveland Clinic Taussig Cancer Institute
Avatar

SIMPLIFY-2 Trial: Momelotinib Vs. Continued Ruxolitinib or Best Available Therapy in Pts With MF Who Require RBC Transfusions

By Cleveland Clinic Taussig Cancer Institute FEATURING Aaron Gerds
By Cleveland Clinic Taussig Cancer Institute FEATURING Aaron Gerds
297 views
June 28, 2024
Comments 0
Login to view comments. Click here to Login

Featured Video

37:21
Amgen Sponsorship

New Approval for Frontline Consolidation in Patients with CD19-posit…

Feat. J. Mccloskey

Featured Video

07:44
Incyte

Optimizing the Management of Patients with Polycythemia Vera (PV)

Feat. P. Bose, R. Rampal

Recommended

24:08

Evaluation, Diagnosis, Prognostication, and Emerging Therapies for M…

Indy Hematology Review

A. Tefferi

1.4K views
24:35

Current Approaches in the Treatment of Myeloproliferative Neoplasms

Indy Hematology Review

A. Tefferi

1.3K views
14:01

ESMO 2024 Summary: Highlights in Heme Malignancies

2024 ESMO Annual Meeting Insights Hub

M. Gomes da Silva

426 views
27:37

Review of Myeloproliferative Neoplasms

Indy Hematology Review

A. Tefferi

2.7K views
18:04

Momelotinib for Myelofibrosis: Top 10 Things You Should Know Post-FD…

Ruben Mesa

932 views
16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison
16:26
Incyte

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison
20:15

Current and Future Treatment Landscape of Myelofibrosis

XV Eurasian Hematology-Oncology Congress - EHOC 2024

R. Komrokji

140 views
25:44

Myeloid Malignancies: Hot Topics in 2024

Yale Cancer Center

N. Podoltsev

174 views
24:48

2024 Updates on Myelofibrosis and Systemic Mastocytosis

Indy Hematology Review

R. Rampal

327 views
21:52

ASH 2023 Summary: "MF, ET, and PV - Highlights and Clinical Implicat…

Insights from 2023 ASH Annual Meeting

D. Tremblay

403 views
10:02

ASH 2023 Summary: "The Best of MPNs - Highlights & Key Takeaways"

Insights from 2023 ASH Annual Meeting

R. Mesa

359 views
18:42

Key Updates in AML, MDS, & MF From ASH

Memorial Sloan Kettering Cancer Center

A. Goldberg

297 views
15:43
Incyte

Importance of Early Management of Patients with Myelofibrosis (MF)

Feat. P. Bose, R. Rampal
15:14

Safety Profile of Ruxolitinib in Patients With MF

Icahn School of Medicine at Mount Sinai

D. Tremblay

858 views
11:39

2024 Updates in Myeloproliferative Neoplasms

Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient

E. Hexner

301 views
17:23

Management of MF After Ruxolitinib Failure

Vanderbilt University Medical Center (VUMC)

A. Kishtagari

169 views
35:48

Experts Discuss How They Choose 2L Therapy in MF

MyCancerHaven

R. Vij, P. Bose

145 views
08:11

Counseling Patients With Newly Diagnosed PV or ET

Krisstina Gowin

204 views
11:03

Current Treatment Landscape of JAK Inhibitors in MF

Moffitt Cancer Center

A. Kuykendall

231 views
AUTOPLAY